Press Releases

Mithra Announces Completion of Recruitment in Donesta® Phase II Study
13 October 2017
EN FR

Mithra’s Marketing Authorization Application for Tibelia® Accepted by Health Canada
10 October 2017
EN FR

Mithra Signs Commercial Agreement With Brazilian Leader in Women’s Health Libbs for Estelle® in Brazil
26 September 2017
EN FR

Mithra announces 2017 half year results
21 September 2017
EN FR

Half year 2017 Results
21 September 2017
EN FR

Mithra Announces First Subject Completes Estelle® Phase III Study
18 August 2017
EN FR

Recruitment Completed in Estelle® Population PK Substudy
9 August 2017
EN FR

Mithra Submits Myring™ for European Marketing Approval
17 July 2017
EN FR

Mithra Strengthens E4 Patent Position in Australian Market
6 July 2017
EN FR

Mithra Signs Exclusive License and Supply Agreement with Fuji Pharma for Donesta® in Japan and Asean
28 June 2017
EN FR

Information on the total number of voting rights (denominator)
27 June 2017
EN FR

Estelle® Phase IIB Results on Well-Being and Body Weight Published in Leading Peer-Reviewed journal
26 June 2017
EN FR